Publications

Detailed Information

The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study

DC Field Value Language
dc.contributor.authorYang, Jae Jeong-
dc.contributor.authorKo, Kwang-Pil-
dc.contributor.authorCho, Lisa Y.-
dc.contributor.authorShin, Aesun-
dc.contributor.authorChang, Soung-Hoon-
dc.contributor.authorYoo, Keun-Young-
dc.contributor.authorPark, Sue K.-
dc.contributor.authorKang, Daehee-
dc.contributor.authorShin, Hai-Rim-
dc.contributor.authorGwack, Jin-
dc.date.accessioned2012-06-27T00:21:21Z-
dc.date.available2012-06-27T00:21:21Z-
dc.date.issued2009-07-17-
dc.identifier.citationBMC CANCER; Vol.9 ;238ko_KR
dc.identifier.issn1471-2407-
dc.identifier.urihttps://hdl.handle.net/10371/77496-
dc.description.abstractBackground: The aim of this study was to investigate the role of TNF genetic variants and the combined effect between TNF gene and cigarette smoking in the development of gastric cancer in the Korean population. Methods: We selected 84 incident gastric cancer cases and 336 matched controls nested within the Korean Multi-Center Cancer Cohort. Six SNPs on the TNF gene, TNF-alpha-238 G/A, -308 G/A, 857 C/T, -863 C/A, -1031 T/C, and TNF-beta 252 A/G were genotyped. The ORs (95% CIs) were calculated using unconditional logistic regression model to detect each SNP and haplotype-pair effects for gastric cancer. The combined effects between the TNF gene and smoking on gastric cancer risk were also evaluated. Multi dimensionality reduction (MDR) analyses were performed to explore the potential TNF gene-gene interactions. Results: TNF-alpha-857 C/T containing the T allele was significantly associated with an increased risk of gastric cancer and a linear trend effect was observed in the additive model (OR = 1.6, 95% CI 1.0-2.5 for CT genotype; OR = 2.6, 95% CI 1.0-6.4 for TT genotype). All haplotype-pairs that contained TCT or CCC of TNF-alpha-1031 T/C, TNF-alpha-863 C/A, and TNF-alpha-857 C/T were associated with a significantly higher risk for gastric cancer only among smokers. In the MDR analysis, regardless of smoking status, TNF-alpha-857 C/T was included in the first list of SNPs with a significant main effect. Conclusion: TNF-alpha-857 C/T polymorphism may play an independent role in gastric carcinogenesis and the risk for gastric cancer by TNF genetic effect is pronounced by cigarette smoking.ko_KR
dc.language.isoenko_KR
dc.publisherBIOMED CENTRAL LTDko_KR
dc.titleThe role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control studyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor양재정-
dc.contributor.AlternativeAuthor고광필-
dc.contributor.AlternativeAuthor신애선-
dc.contributor.AlternativeAuthor곽진-
dc.contributor.AlternativeAuthor장성훈-
dc.contributor.AlternativeAuthor신해림-
dc.contributor.AlternativeAuthor유근영-
dc.contributor.AlternativeAuthor강대희-
dc.contributor.AlternativeAuthor박수경-
dc.identifier.doi10.1186/1471-2407-9-238-
dc.citation.journaltitleBMC CANCER-
dc.description.citedreferenceLevitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058-
dc.description.citedreferenceLadeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y-
dc.description.citedreferenceZhang JY, 2008, J HUM GENET, V53, P479, DOI 10.1007/s10038-008-0273-3-
dc.description.citedreferenceGingo MR, 2008, EUR RESPIR J, V31, P1005, DOI 10.1183/09031936.00100307-
dc.description.citedreferenceBatty GD, 2008, ANN ONCOL, V19, P996, DOI 10.1093/annonc/mdm578-
dc.description.citedreferenceGorouhi F, 2008, BRIT J CANCER, V98, P1443, DOI 10.1038/sj.bjc.6604277-
dc.description.citedreferenceZhang C, 2008, CHINESE MED J-PEKING, V121, P597-
dc.description.citedreferenceBrandsma CA, 2008, INHAL TOXICOL, V20, P183, DOI 10.1080/08958370701821342-
dc.description.citedreferenceGarcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x-
dc.description.citedreferenceJang Y, 2007, CLIN CHIM ACTA, V377, P221, DOI 10.1016/j.caa.2006.10.002-
dc.description.citedreferenceSjodahl K, 2007, INT J CANCER, V120, P128, DOI 10.1002/ijc.22157-
dc.description.citedreferenceOzasa K, 2007, ASIAN PAC J CANCER P, V8, P89-
dc.description.citedreferenceHou L, 2007, CARCINOGENESIS, V28, P118, DOI 10.1093/carcin/bg1130-
dc.description.citedreferenceSugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x-
dc.description.citedreferenceKIM Y, 2007, J PREV MED PUBLIC HL, V40, P467-
dc.description.citedreferenceNishino Y, 2006, JPN J CLIN ONCOL, V36, P800, DOI 10.1093/jjco/hyl112-
dc.description.citedreferenceHamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x-
dc.description.citedreferenceGwack J, 2006, BRIT J CANCER, V95, P639, DOI 10.1038/sj.bjc.6603309-
dc.description.citedreferenceBennet AM, 2006, ATHEROSCLEROSIS, V187, P408, DOI 10.1016/j.atherosclerosis.2005.09.022-
dc.description.citedreferenceMoore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036-
dc.description.citedreferenceKamangar F, 2006, CANCER CAUSE CONTROL, V17, P117, DOI 10.1007/s10552-005-0439-7-
dc.description.citedreferenceShin A, 2005, BRIT J CANCER, V92, P1273, DOI 10.1038/sj.bjc.6602467-
dc.description.citedreferenceLu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349-
dc.description.citedreferenceZambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.10.013-
dc.description.citedreferenceBarrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457-
dc.description.citedreferenceMoore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795-
dc.description.citedreferenceLee SG, 2004, CYTOKINE, V28, P75, DOI 10.1016/j.cyto.2004.06.009-
dc.description.citedreferenceMachado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0-
dc.description.citedreferenceEl-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4-
dc.description.citedreferenceHahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869-
dc.description.citedreferenceHAMAJIMA N, 2003, GASTRIC CANCER, V6, P230-
dc.description.citedreferencePark CY, 2002, J CLIN MICROBIOL, V40, P4753, DOI 10.1128/JCM.40.12.4753-4756.2002-
dc.description.citedreferenceChurg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC-
dc.description.citedreferenceGabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424-
dc.description.citedreferenceYOO KY, 2002, ASIAN PAC J CANCER P, V3, P85-
dc.description.citedreferenceYea SS, 2001, J CLIN PATHOL, V54, P703-
dc.description.citedreferenceJang WH, 2001, CANCER LETT, V166, P41-
dc.description.citedreferenceKunstmann E, 1999, ELECTROPHORESIS, V20, P1756-
dc.description.citedreferenceTAPPIA PS, 1995, CLIN SCI, V88, P485-
dc.description.citedreferenceBENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289-
dc.description.citedreference*IARC, 1994, IARC MON EV CARC RIS, V61, P177-
dc.description.citedreferenceQIN ZH, 1993, J EXP MED, V178, P355-
dc.description.tc4-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share